RVS161 Antibody

What is RVS161 and why is it significant for fungal research?

RVS161 is a BAR domain protein that plays essential roles in plasma membrane function, particularly in fungi like Candida albicans and Saccharomyces cerevisiae. Its significance stems from its involvement in critical cellular processes including endocytosis, morphogenesis, and actin patch polarization. In C. albicans, RVS161 contributes significantly to virulence, as deletion mutants (rvs161Δ) show reduced invasive growth and altered cell wall construction that exposes proinflammatory components to host immune systems . The protein localizes to cortical actin patches and exhibits polarization to nascent bud sites during bud emergence and to the bud neck in dividing cells . Understanding RVS161 function provides insights into fundamental membrane dynamics and fungal pathogenesis mechanisms.

How are functional RVS161 antibodies typically generated for research applications?

Generation of functional RVS161 antibodies typically involves a recombinant protein expression approach. The established protocol includes:

• Cloning the complete RVS161 coding sequence into a bacterial expression vector (e.g., pET-30c(+))

• Expressing a His6x-tagged RVS161 fusion protein in bacterial systems like BL21(DE)

• Inducing protein expression with 1mM IPTG for approximately 3 hours at 37°C

• Cell lysis with 100 μg/ml lysozyme and 0.1% Triton X-100 followed by sonication

• Solubilizing inclusion bodies in binding buffer containing 8M urea

• Affinity purification using Ni-NTA resin chromatography with imidazole elution gradient

• Dialysis of purified protein into PBS

• Immunization of research animals (typically New Zealand white rabbits) to generate polyclonal antisera

This approach yields antibodies capable of recognizing native RVS161 in various experimental contexts, though functionality testing through immunofluorescence and western blotting is essential.

What experimental limitations should researchers consider when working with RVS161 antibodies?

Several important limitations require consideration when designing experiments with RVS161 antibodies:

• Extreme sensitivity to fixation conditions - RVS161 antigenicity and subcellular localization are highly susceptible to disruption by chemical fixation methods, potentially yielding inconsistent results in immunofluorescence studies

• Functional validation challenges - When using GFP-tagged RVS161 as an alternative detection method, researchers must verify functionality, as studies have shown that some fusion proteins (particularly certain RVS161-GFP constructs) fail to rescue rvs161Δ mutant defects

• Species-specific considerations - Antibodies generated against S. cerevisiae RVS161 may not cross-react effectively with C. albicans RVS161 despite sequence similarity, necessitating species-specific antibody production

• Complex formation interference - RVS161 forms functional complexes with other proteins that may mask antibody epitopes, potentially affecting detection efficiency

• Membrane association challenges - As RVS161 associates with detergent-resistant membrane fractions, standard protein extraction protocols may yield suboptimal results

What are the optimal protocols for immunolocalization of RVS161 in fungal cells?

Successful immunolocalization of RVS161 requires careful optimization of several parameters:

Sample Preparation:

• Minimal fixation (1-2% formaldehyde for 5-10 minutes) to preserve epitope accessibility

• Careful cell wall digestion for improved antibody penetration

• Gentle permeabilization with low detergent concentrations

Imaging Parameters:

• Co-staining with F-actin markers (e.g., phalloidin) to confirm actin patch localization

• Latrunculin A treatment controls to demonstrate F-actin dependency of localization

• Cell cycle synchronization to capture dynamic localization patterns

Validation Approaches:

• Parallel visualization with functional RVS161-GFP fusions

• Confirmation with multiple antibodies recognizing different epitopes

• Negative controls using rvs161Δ strains

Research indicates that native RVS161 typically exhibits both patch localization at cortical actin structures and diffuse cytoplasmic distribution . This pattern changes dynamically throughout the cell cycle, with notable polarization to nascent bud sites and bud necks in dividing cells. F-actin depolymerization with latrunculin A abolishes patch localization, confirming the actin-dependency of this distribution pattern .

How can researchers effectively use RVS161 antibodies to study membrane domain organization?

RVS161 antibodies provide valuable tools for investigating specialized membrane domains through several methodological approaches:

Biochemical Fractionation Analysis:

• Isolation of detergent-resistant membrane fractions

• Quantitative western blotting with RVS161 antibodies to determine protein distribution

• Comparison with lipid raft markers to establish domain correlation

Correlative Microscopy:

• Co-immunostaining for RVS161 and membrane lipid markers

• Filipin staining to visualize sterol-rich domains at hyphal tips

• Quantitative colocalization analysis with membrane domain markers

Drug Perturbation Studies:

• Treatment with agents that disrupt ergosterol organization (e.g., fluconazole)

• Analysis of RVS161 redistribution in response to membrane alterations

• Correlation with functional changes in endocytosis efficiency

Research has demonstrated that RVS161 localizes to ergosterol- and sphingolipid-enriched plasma membrane domains that resemble lipid rafts . Interestingly, while rvs161Δ mutants show defects in endocytosis and actin patch polarization, other plasma membrane constituents remain properly localized, including filipin-stained sterol-rich domains at hyphal tips . This suggests that RVS161 functions downstream of initial membrane domain organization.

What approaches can determine if RVS161 antibodies interfere with protein-protein interactions?

Determining whether RVS161 antibodies interfere with protein-protein interactions requires systematic experimental approaches:

Epitope Mapping:

• Generation of truncated RVS161 constructs to identify antibody binding regions

• Correlation with known interaction domains from structural studies

• Competitive binding assays with purified interacting proteins

Functional Interference Assays:

• In vitro binding assays with and without antibody presence

• Co-immunoprecipitation efficiency comparison using different antibody concentrations

• Split-reporter assays (e.g., yeast two-hybrid) with antibody introduction

Direct Visualization Approaches:

• FRET analysis between labeled interaction partners with antibody titration

• Single-molecule tracking to detect changes in protein complex dynamics

• Native PAGE analysis of complex stability in antibody presence

Research has established that RVS161 interacts with Fus2p during cell fusion in yeast , and forms functional complexes with RVS167 . Antibodies that recognize epitopes within interaction interfaces may disrupt these functional associations, potentially affecting experimental outcomes in ways that require careful control experiments.

How can RVS161 antibodies help elucidate the relationship between endocytosis and fungal virulence?

RVS161 antibodies offer several sophisticated approaches to investigate the endocytosis-virulence connection:

Infection Model Analysis:

• Immunohistochemistry of infected tissues to track RVS161 distribution during pathogenesis

• Comparison of protein expression and localization between invasive and non-invasive growth

• Correlation with markers of active endocytosis in microabscess formation

Host-Pathogen Interface Studies:

• Antibody-based detection of RVS161 redistribution during host cell contact

• Analysis of protein dynamics during phagocytosis by immune cells

• Quantification of endocytic activity in different infection microenvironments

Comparative Analysis:

• RVS161 distribution comparisons between virulent and avirulent strains

• Correlation between endocytic efficiency and tissue invasion capacity

• Mapping of post-translational modifications during infection progression

Research has revealed that rvs161Δ mutants exhibit greatly reduced virulence in mouse models despite being capable of growing to high levels in kidneys. These mutants form large fungal masses walled off by leukocytes rather than disseminated microabscesses typical of wild-type infection . This suggests that RVS161-mediated endocytosis contributes to tissue invasion and immune evasion, areas where antibody-based detection can provide critical insights.

What methodological approaches can distinguish between RVS161 and RVS167 functional roles using antibodies?

Distinguishing the overlapping but distinct roles of RVS161 and RVS167 requires sophisticated antibody-based approaches:

Differential Localization Analysis:

• Dual immunofluorescence with specific antibodies against each protein

• Super-resolution microscopy to resolve subtle differences in distribution patterns

• Temporal analysis of localization dynamics during cellular processes

Selective Co-immunoprecipitation:

• Parallel immunoprecipitations with antibodies against each protein

• Comparative mass spectrometry to identify unique interaction partners

• Sequential immunoprecipitation to isolate distinct protein complexes

Conditional Phenotype Analysis:

• Antibody microinjection to acutely inhibit specific proteins

• Correlation of functional defects with protein-specific inhibition

• Rescue experiments with recombinant proteins in antibody-inhibited cells

Pathway-Specific Functional Assays:

• Quantitative endocytosis assays (e.g., FM4-64 uptake) with selective antibody inhibition

• Drug sensitivity profiles (e.g., fluconazole, histatin 5) in relation to specific protein function

• Cell wall integrity measurements correlated with specific protein activity

Research demonstrates that while both proteins contribute to similar processes, rvs161Δ mutants show more severe defects in endocytosis and morphogenesis than rvs167Δ mutants . Additionally, rvs161Δ exhibits increased sensitivity to fluconazole while rvs167Δ shows increased resistance, indicating distinct cellular functions .

How can researchers use RVS161 antibodies to investigate stress response mechanisms in fungi?

RVS161 antibodies provide valuable tools for understanding stress response mechanisms through several methodological approaches:

Stress-Induced Redistribution:

• Immunolocalization of RVS161 under various stress conditions (osmotic, oxidative, pH)

• Time-course analysis of protein relocalization during stress adaptation

• Co-localization with stress response pathway components

Post-Translational Modification Analysis:

• Immunoprecipitation followed by modification-specific detection methods

• Comparison of modification patterns under normal and stress conditions

• Correlation with activation of specific stress response pathways

Functional Response Measurements:

• Quantitative endocytosis assays under stress conditions with antibody manipulation

• Analysis of membrane reorganization with selective inhibition of RVS161

• Correlation of stress survival with protein-specific activity

Pathway Integration Studies:

• Antibody-based isolation of RVS161-containing complexes under stress

• Identification of stress-specific interaction partners

• Mapping of RVS161 within stress signaling networks

Research indicates that RVS161 plays important roles in stress responses, as mutants show hypersensitivity to various stressors including high salt conditions and cell wall-perturbing agents . Additionally, rvs161Δ mutants exhibit altered responses to antimicrobial peptides and antifungal drugs , suggesting RVS161's involvement in cellular stress adaptation mechanisms.

Why might western blotting with RVS161 antibodies yield inconsistent results?

Several technical factors can contribute to inconsistent western blotting results with RVS161 antibodies:

Sample Preparation Challenges:

• Incomplete solubilization of membrane-associated RVS161

  • Solution: Include stronger detergents (0.5-1% SDS) or chaotropic agents (8M urea) in lysis buffers

• Protein degradation during extraction

  • Solution: Use multiple protease inhibitors and process samples rapidly at 4°C

• Post-translational modifications affecting epitope recognition

  • Solution: Treat samples with appropriate enzymes (phosphatases, deglycosylases) before analysis

Blotting Optimization Requirements:

• Inefficient transfer of hydrophobic domains

  • Solution: Add 0.1% SDS to transfer buffer and use PVDF membranes

• High background due to non-specific binding

  • Solution: Optimize blocking conditions (try 5% BSA instead of milk)

• Epitope masking during gel electrophoresis

  • Solution: Vary sample denaturation conditions (temperature, reducing agents)

Antibody-Specific Considerations:

• Lot-to-lot variability in polyclonal antibodies

  • Solution: Validate each new antibody lot and maintain reference standards

• Concentration-dependent performance characteristics

  • Solution: Perform systematic titration experiments to determine optimal concentration

• Storage-related deterioration

  • Solution: Aliquot antibodies, avoid freeze-thaw cycles, add stabilizing proteins

Research indicates that RVS161 typically appears as a ~30 kDa band, but detection may be complicated by its membrane association properties and potential post-translational modifications .

What controls are essential when using RVS161 antibodies for immunoprecipitation studies?

Rigorous immunoprecipitation studies with RVS161 antibodies require multiple controls:

Genetic Controls:

• Wild-type vs. rvs161Δ strains to confirm specificity

• RVS161 overexpression samples to verify signal correlation with protein levels

• RVS161 point mutants that affect specific functions to map functional domains

Technical Controls:

• Pre-immune serum controls to identify non-specific binding

• Isotype-matched irrelevant antibody controls

• Competitive binding with purified antigen to demonstrate specificity

• Reciprocal immunoprecipitation with antibodies against known interacting partners

Validation Approaches:

• Mass spectrometry identification of immunoprecipitated proteins

• Western blot confirmation of co-precipitated proteins

• Activity assays of immunoprecipitated complexes to confirm functionality

Condition Controls:

• Detergent type and concentration optimization

• Salt concentration series to distinguish high and low-affinity interactions

• Crosslinking vs. non-crosslinking conditions to capture transient interactions

When studying RVS161 interactions, researchers should be aware that RVS161 forms complexes with proteins like Fus2p during specific cellular processes such as mating , and these interactions may be condition-dependent, requiring appropriate experimental design to capture effectively.

How can researchers differentiate between direct and indirect effects when studying RVS161 function with antibodies?

Distinguishing direct from indirect effects requires sophisticated experimental approaches:

Temporal Resolution Studies:

• Acute inhibition with antibody microinjection/electroporation

• Time-course analysis to separate immediate from delayed effects

• Pulse-chase approaches to track specific cellular processes

Spatial Resolution Approaches:

• Targeted inhibition using locally applied antibodies

• Correlation of localized antibody binding with functional effects

• Subcellular fractionation to isolate compartment-specific effects

Molecular Dissection:

• Domain-specific antibodies to inhibit select functions

• Correlation with specific point mutations affecting distinct functions

• Rescue experiments with domain-swapped chimeric proteins

Pathway Analysis:

• Systematic analysis of upstream and downstream pathway components

• Identification of the earliest detectable changes after antibody treatment

• Computational modeling of direct vs. indirect effect propagation

Research on RVS161 function demonstrates complex relationships between different cellular processes. For example, the endocytosis defects in rvs161Δ mutants correlate with altered cell wall properties and changes in drug sensitivity , making it challenging to determine which effects are direct consequences of RVS161 dysfunction versus secondary adaptations.

How can RVS161 antibodies contribute to understanding fungal invasion mechanisms?

RVS161 antibodies offer unique insights into fungal invasion mechanisms through several methodological approaches:

Invasion Interface Analysis:

• Immunolocalization during different stages of tissue penetration

• Correlation of RVS161 redistribution with invasive growth transitions

• Co-visualization with host barrier components during invasion

Dynamic Process Tracking:

• Quantitative analysis of endocytosis rates during invasion using antibody-based assays

• Correlation between actin patch polarization and invasive growth efficiency

• Membrane domain reorganization monitoring during host surface contact

Comparative Pathogenesis Studies:

• Analysis of RVS161 expression and distribution across clinical isolates with varying invasiveness

• Correlation between antibody-detectable protein levels and invasion capacity

• Species-specific differences in RVS161 function during pathogenesis

Research demonstrates that rvs161Δ mutants grow less invasively in agar and show greatly reduced virulence in mouse models . Histological analyses reveal that these mutants grow as large fungal masses walled off by leukocytes rather than forming disseminated microabscesses typical of wild-type infection, suggesting critical roles for RVS161 in tissue penetration and dissemination that can be further elucidated with antibody-based approaches .